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Abstract
Background: National guidelines on MRSA (methicillin-resistant Staphylococcus aureus) screening policy in England
have changed on a number of occasions, but there is limited data on its influence at a local level. The aim of this
study was to determine if changes in National policy influenced preoperative screening of cataract patients for
MRSA.
Methods: A structured telephone survey was conducted on all 133 ophthalmology units in England in 2004 and
again in 2007 for the initial responders, after a change in national policy.
Results: A total of 74 units (56%) responded in 2004 and 71 units (96% of initial respondents) in 2007. In 2004,
57% of units screened for MRSA. They screened groups at high risk of carriage, including patients with previous
MRSA (93%) and patients from Nursing homes (21%). Swab sites included the nose (100%), eyes (31%) and
perineum (62%). In 2007, there was no significant change in the number of units that screened for MRSA (57% vs
66%; p =0.118; McNemar test). However, more units screened for MRSA in patients from nursing/residential homes
(21% vs 51%; p=0.004, McNemar test), and in patients who had recent admission to hospital (12% vs 36%; p=0. 00 3) .
In the second survey, 3 units (6%) now screened patients who were close relatives of MRSA carriers.
Conclusion: This survey has highlighted inconsistences in MRSA screening practice of day-case cataract surgery
patients across England after 2 major national policy changes. A change in DoH policy only led to more units
screening patients for MRSA from high risk groups.
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Background
In the UK, hospital acquired infections (HAIs) are esti-
mated to affect 9% of inpatients, with a cost of £1 billion
per annum to the National Health Service (NHS) [1].
Twenty percent (20%) of HAIs are caused by methicillin-
resistant Staphylococus aureus (MRSA). Since the mid-
1990s, this so-called ‘hospital superbug’ was a topic of
media and political concern in the UK [2].
Revised guidelines published in 1998 addressed MRSA
control in English hospitals through a more flexible
‘targeted’ approach rather than the initial ‘search and des-
troy’ principle [3]. Patients were stratified according to the
level of perceived risk to them from MRSA and a range of
management options were described for each level of risk.
According to these guidelines, elective cataract surgery
was considered as low risk, thus preoperative screening
was not necessary.
The increasing politicisation of MRSA and a review of
our preoperative assessment procedures for patients
undergoing cataract surgery prompted us to question
whether MRSA screening should take place. We con-
ducted a questionnaire to ascertain the practice of oph-
thalmology departments across England in 2004. Another
survey of the initial respondents was carried out again in
2007 to see if the policy in these departments had changed
since the publication of new the UK MRSA guidance [4]
and the England Department of Health (DoH) document
on MRSA screening [5].
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A structured telephone questionnaire (Table 1) was con-
ducted for all National Health Service (NHS) ophthal-
mology units in England listed in the Royal college of
Ophthalmologists’ Directory of Training Posts 2003–
2004 [6]. A total of 133 units were identified. This was
initially carried out in March-June 2004 and again, for
all initial respondents, in May-July 2007 to determine if
changes in practice had occurred. Our point of contact
in each unit was a member of staff undertaking the pre-
assessment of cataract patients. At least 3 attempts were
made to contact staff.
This research did not involve human data or material,
hence ethical approval was not sought for this study.
Quantitative analysis- statistical tests
The McNemar’s test for categorical dichotomous (Yes/No
answers) paired data was used to compare questions in
2004 vs 2007 and determine if any significant change in
policy on MRSA screening had occurred. 2 × 2 contin-
gency tables were constructed for each of the questions
asked above.
Qualitative analysis
Free text comments made by respondents were docu-
mented; common themes were identified and coded (based
on basis of screening practice) before data analysis by one
of the authors (LJ).
Results
Initial survey
Response rate
In the initial 2004 survey, 74 (56%) units responded out
of a total of 133 in England (Table 2). The units that did
not respond included those that felt the survey was too
sensitive in nature (they were concerned about risk
information becoming available to the media) whereas
other units could not be contacted despite several
attempts.
Units that screened for MRSA in high risk groups
43% of units screened no pre-operative cataract patients
for MRSA. The units that did screen for MRSA (57%),
screened groups at high risk of carriage, including patients
with previous MRSA (93%), patients from nursing homes
(21%), patients from other hospitals (21%), recent his-
tory of admission for any reason (12%; range varied
6–18 months) and patients from abroad (12%).
Table 1 Structured telephone questionnaire
Number Question
1 Does your department routinely screen any preoperative
cataract patients for MRSA?
2 Which groups of patients do you screen?
3 Which sites do you take a swab from?
4 If patients are found to be positive, who treats them?
5 Have you ever had a case of MRSA endophthalmitis?
Table 2 MRSA screening practices for preoperative
cataract surgery patients in English units in 2004 and
2007
2004 2007
Total % Total %
Response
Yes 74 56 71 96
No 133 44 3 4
Screen for MRSA
Yes 42 57 47 66
No 32 43 24 34
Groups screened for MRSA
Nursing/Residential Home* 9 21 24 51
Recent Hospital Admissions* 5 12 17 36
Previously MRSA + ve 39 93 38 81
Overnight Stay 4 10 4 9
From Hospitals abroad 5 12 6 13
Other Hospitals 8 19 8 17
Wounds/Indwelling catheters 9 21 14 30
Close relatives of MRSA carriers 0 0 3 6
Diabetics 0 0 1 2
Sample Sites for Swab
Don’t Know 1 2.5 2 4
GP informed 2 5 1 2
Nose 39 100 43 98
Eye 12 31 8 18
Throat 15 38 18 41
Axilla 11 28 12 27
Groin/Perineum 24 62 23 52
Wounds/Catheters 9 23 14 32
1 site 6 15 5 11
More than 1 site 33 85 39 89
Treatment Responsibility
Don’t Treat- Placed Last on List 6 14 0 0
GP* 31 74 42 93
Infection Control 5 12 6 13
Eye Nurse 3 7 4 9
Combination 6 14 7 16
Case of MRSA endophthalmitis 4/74 2/71
Survey in 2007 was repeated with initial responders only.
*Indicates that there was a significant difference between the paired
responses in 2004 vs 2007 (Mc Nemar test).
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If a patient did require screening, 2 units would inform
the General Practioner (GP or primary care physician)
to make necessary arrangements for swabs but the unit
would not swab the patient themselves. 1 unit was not
certain what sites were required to be sampled. For the
other 39 units, swab sites included the nose (100%),
groin (62%), throat (38%), axilla (28%), wounds/catheters
(23%) and the eye (31%). 15% of units swabbed from a
single site only.
Responsibility for treatment (eradication therapy)
After screening, if MRSA was identified, 6 units (14%)
would not treat patients but on the day of the admission,
isolate them and place them at the end of the list. Of those
that treated, a number of health professionals were respon-
sible for the treatment of MRSA colonisation (eradication
therapy). GPs were asked to treat in 31 units (79%), a mem-
ber of the eye team treated patients in 3 units (7%) and the
infection control team treated them in 5 units (7%).
Experience of MRSA endophthalmitis
4 units (5%) were aware of at least one case of MRSA
endophthalmitis. Out of these, 1 unit did not screen for
MRSA.
Comparison with second survey
Response rate
The second telephone survey in 2007, involved the 74
responders to the initial survey. Contact with 71 units
was successful (96%). Two units refused to answer any
questions due to the sensitive nature (and 1 unit could
not be contacted.
High risk groups that were screened
In 2007, 47 units (66%) screened high-risk preoperative
patients for MRSA compared with 42 (57%) units in
2004. 10 additional units started to screen for MRSA in
high risk groups, however, 3 units stopped screening any
patients for it. For the paired responses, there was no sig-
nificant change in the decision to screen for MRSA be-
tween 2004 and 2007 (p=0.11 8;n=37, McNemar test).
More units screened for MRSA in patients from nursing/
residential homes (51% vs 21%) and this was a signifi-
cant change for the paired responses (p=0. 00 4, n=37 ,
McNemar test). Screening of recent hospital admissions
also increased (36% vs 12%), which was also a significant
change (p=0.00 3 ; n=37, McNemar test). In the second
survey, 3 units (6%) now screened a new high risk group -
patients who were close relatives of MRSA carriers.
Screening method-sample site
The nose was still the primary swab site for 98% of units,
however 1 unit now swabbed wounds only for MRSA.
There was no significant change in sample sites for the
paired responses (p>0.10; McNemar test).
Treatment responsibility
In 2007, more units stated that the responsibility for
MRSA eradication therapy was with the GP (93% vs
74%). The source of these new responses were from the
units that had started to screen in 2007, so there was no
significant change in the paired responses (p=0.18;
McNemar test). In 2004, 5 out of the 6 units that did
screen, but did not treat positive patients (instead prefer-
ring to place them at the end of the list), now treated
these patients in 2007.
Other comments by respondents
Other comments by the respondents have been sum-
marised in Table 3.
Discussion
The results of this survey highlight the inconsistencies
in the policy of eye departments in England for the pre-
operative screening for MRSA in patients undergoing
cataract surgery. It seems that either some units are
using resources to unnecessarily screen and treat pa-
tients, or other units are putting patients at unnecessary
risk of MRSA infection by not screening. A postal survey
has been conducted previously in 2005 [7], prior to the
recent DoH (England) and UK guidelines, which demon-
strated a similar percentage (67%) of UK eye depart-
ments screening for MRSA prior to cataract surgery.
Our survey extends these findings by determining if
there was any significant change in practice before and
after a change in DoH guidelines.
Table 3 Selected comments by respondents
Selected comments
1 Reasons for not screening:
”microbiology says it costs too much”, “swabs were not being
followed up and GP doesn’t always treat”, “we rely on swabs from
previous admissions, which if positive, result in a patient being
placed at the end of the operating list”
2 The reason given for not screening anymore in 2007:
”we had a new policy given by infection control”
3 The reason given why policy changed to start screening in 2007:
”new infection control policy to screen all elective surgeries.
We did this for 3 months but microbiology then stated that for
cataract surgery it should be limited to high risk patients”
4 Unit that did not screen for MRSA, despite having a case of MRSA
endophthalmitis:
”it was a community-acquired strain”
5 Change in swab sites:
”swabbing the groin was no longer appropriate in an eye clinic,
and were told the nose is sufficient now”
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guidance available for MRSA screening in the hospital
setting was based on those suggested by the combined
Working Party [3]. These offered flexibility by allowing
individual hospitals to interpret these guidelines in the
context of the local situation. However, it was not clear
what the implications were for preoperative screening
for patients undergoing cataract surgery.
When the second survey was conducted in 2007 a
number of developments had occurred. This included
the UK MRSA guidance [4] and DoH (England) docu-
ment on screening for MRSA colonisation [5]. These
guidelines stated that certain high risk groups should be
screened routinely, but the guidelines acknowledged the
importance of local infection control teams in deciding
who should be screened. The definition of high risk
patients depended on the MRSA risk status of the
unit, the reason for admission (acute vs elective) and
the likelihood of the patient being an MRSA carrier.
Thus, elective cataract surgery patients would be clas-
sified as low risk.
Nevertheless, patients at high risk of carriage may have
to be screened. The UK guidelines are explicit in recom-
mending this [4]: “All patients who are at high risk for
carriage of MRSA should be screened at the time of
admission, unless .... being admitted to isolation facilities
and it is not planned to attempt to clear them of MRSA
carriage”. However, the DoH (England) document [5] is
less prescriptive and suggests that “trusts should consider
how local risk assessment can be done and screening im-
plemented for these patient groups”. In our survey, al-
though there was no significant change in the policy to
screen for MRSA (57% vs 66%), the recent guidelines may
have influenced some of the significant changes in practice
that occurred when the second survey was carried out in
2007. In 2007, our survey of the initial respondents from
2004 demonstrated that more units were screening for
MRSA in patients with a high risk of carriage (ie patients
from nursing/residential homes, recent hospital admis-
sions or close relatives of MRSA carriers). The practice
to screen patients with a history of MRSA colonisation/
infection remained the same during this period.
The variability between units regarding which groups
to screen for MRSA may also be explained by the DoH
(England) guidelines since they acknowledge the import-
ance of local infection control teams in deciding who should
be screened [5]. Thus, the decision by units not screen for
MRSA, even in patients with high risk for carriage, may
have been based on a sound local risk assessment.
So should patients undergoing cataract surgery, who
are at high risk for carriage, be screened for MRSA? A
risk assessment on MRSA carriers may be based on two
concerns: the incidence and impact of an MRSA infec-
tion (ie endophthalmitis) and the risk of transmitting
MRSA to others. To our knowledge, there is no reported
evidence that MRSA MRSA carriage increases the risk
of endophthalmitis. The incidence of MRSA endophthal-
mitis seems to vary. In a case series of 64 consecutive
cases of endophthalmitis, 18.2% (total of 6) of isolates
were identified as MRSA [8]. Another case series in the
USA, demonstrated that MRSA accounted for more than
44% of post-cataract surgery cases [9]. This suggests that
the incidence of MRSA endophthalmitis has increased sig-
nificantly compared to 1.9% of total isolates that were
MRSA in the Endophthalmitis Vitrectomy Study (EVS)
[10]. However, current endophthalmitis prophylaxis mea-
sures using povidone-iodine surgical prep and chloram-
phenicol, are effective against MRSA [11,12].
The outcomes of MRSA endophthalmitis may also
help to guide policy on pre-operative screening. Deramo
et al. [8] found that 67% (total 4) of MRSA-isolates
were associated with poor visual outcome [8]. Better
outcomes were reported in the EVS [10], where 50% of
Staphylococcal aureus cases had a visual acuity (VA) better
than 20/100 (moderate visual loss or better outcome).
However, a more recent case series in the USA demon-
strated that 50% of MRSA cases had severe visual loss
(VA worse than 20/400) [9].
In the survey, one of the units that reported a case of
MRSA endophthalmitis decided not to screen for MRSA
since the community acquired strain was more common
in the locality. However, community acquired MRSA
(CAMRSA) can cause soft tissue infections (lids and or-
bital) that are aggressive and spread rapidly [13]. Most
strains also contain virulence factors such as Panton–
Valentine leukocidin (PVL), a cytotoxin that destroys
neutrophils and macrophages [14].
The final point to address is whether patients who are
MRSA carriers (or high-risk) are a risk of transmitting
MRSA to others. The reduction in the number of units
that swabbed the eye for MRSA pre-operatively (31% vs
18%) may reflect that units may not be concerned about
endophthalmitis but rather a risk of transmission to
others. The DoH document on screening for MRSA col-
onisation briefly states this as a possibility [5]. In the
cataract day-surgery setting, theoretically, the risk of
transfer of carriage of MRSA between patients should be
no higher than in outpatient clinics. The most relevant
setting to cataract day-case surgery alluded to in the UK
MRSA guidance is ambulance transportation. It recom-
mends “most MRSA carriers may be transported with
other patients in the same ambulance without any spe-
cial precautions, other than changing the bedding used
by the carrier” [4]. A history of in-patient stay is an inde-
pendent risk factor for MRSA carriage [15]. However, a
review of the literature revealed a relative paucity of in-
formation relating to outpatient visits, besides a retro-
spective cross-sectional survey which found that for
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an independent risk factor for MRSA carriage, even
when hospitalisation was accounted for [16]. It has also
been found that there is a significant relationship be-
tween the length of hospital stay and the acquisition of
MRSA [17]. Thus, the question remains: does an MRSA
carrier represent a significant risk to others in a short-
stay day surgery ward?
There are several resource implications if a decision
is made to screen selected patients for MRSA car-
riage. At the pre-operative stage it would be necessary
to identify these patients (through specific questions
and to review notes and lab results), then to swab these
patients and initiate treatment, if necessary. This would
all represent an increased burden for the pre-assessment
staff. Furthermore, the UK MRSA guidance suggests
that swab sites should include groin/perineum [4] but
this may not be practical in an eye clinic where a pre-
assessment is being conducted. The DoH (England)
document states that the primary site should be the
nose, since it is the most common carriage site and,
if a carrier is identified, a decolonisation regime should be
started [5].
Ninety three (93)% of units that screened felt primary
care were responsible for instituting decolonisation ther-
apy, but guidance on whether this is appropriate for a
day-case setting is again not clear. Decolonisation in-
cludes 5 days of antibacterial body shampoo and nasal
cream and should be done irrespective of whether facil-
ities are available to isolate the patient [5]. However,
there are concerns that the use of nasal mupirocin anti-
biotic ointment may lead to resistant strains [18] and a
review found that there is insufficient evidence to sup-
port use of topical antimicrobial therapy for eradicating
nasal or extranasal colonisation with MRSA [19]. Never-
theless, the DoH document argues that decolonisation
can significantly reduce the shedding of MRSA, and sub-
sequently, the risk of infection and transmitting MRSA
to others [5].
An alternative to decolonisation may be to set up an
isolation area with barrier measures and to decontamin-
ate the area, but it is believed that the most useful
method to limit MRSA cross infection is careful hand
hygiene between each episode of patient contact [20].
A limitation of our study is that not all units responded
to our survey, nevertheless it does highlight a variation in
screening practices. Contacting the pre-assessment nurses
directly represented a reliable source of answering the
questions posed. Although local infection control teams
can represent an alternative source of information, pre-
assessment nurses would know answers to questions, such
as cases of MRSA endophthalmitis, due to discussion at
regular departmental morbidity meetings which occur in
NHS hospitals.
Conclusions
This survey has highlighted the lack of clarity in current
guidelines on whether day-case cataract surgery patients
at high-risk of MRSA carriage should undergo screening.
For a situation similar to the cataract day-case surgical
setting, there is no strong evidence to suggest that
MRSA carriage increases the risk of endophthalmitis or
whether there is a significant risk of transmitting MRSA
to others.
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